120-46-7
120-46-7 结构式
基本信息
1,3-二苯基-1,3-丙二酮
1,3-二苯基丙二酮
ω-苯甲酰基苯乙酮
二苯甲酰甲烷
二苯甲醯甲烷
二苯甲酰基甲烷, 98+%
1,3-diphenylpropane-1,3-dione
DBM
DIBENZOYLMETHANE
,3-Diphenyl-propane-1,3-dione
1,3-Diphenyl-1,3-propanediamine
1,3-diphenyl-3-propanedione
1,3-Diphenylpropanedione
2-Benzoylacetophenone
3-Propanedione,1,3-diphenyl-1
arenzu dk 2
-Benzoylacetophenone
-Benzoylace-tophenone
Dibenzoylmethan
hodiastab 83
-Hydroxy-chalkone
karenzudk2
omega-Benzoylacetophenone
Phenyl phenacyl ketone
Phenyl-hydroxystyrylketone
物理化学性质
安全数据
应用领域
| 报价日期 | 产品编号 | 产品名称 | CAS号 | 包装 | 价格 |
| 2024/01/25 | HY-W009731 | 二苯甲酰基甲烷 Dibenzoylmethane | 120-46-7 | 500mg | 500元 |
| 2024/01/25 | HY-W009731 | 二苯甲酰基甲烷 Dibenzoylmethane | 120-46-7 | 10mM * 1mLin DMSO | 550元 |
| 2024/01/16 | A13450 | 1,3-二苯基-1,3-丙二酮, 98+% 1,3-Diphenyl-1,3-propanedione, 98+% | 120-46-7 | 25g | 409元 |
常见问题列表
Dibenzoylmethane (10, 20, 30, 40, 50 μM; 6 hours) treatment concentration-dependently increases the mRNA level of HO-1 but has no effect on the mRNA level of Nrf2 in HepG2 cells. Dibenzoylmethane induces HO-1 and Nrf2 protein expression, and the induction diminishes after 12 h.
Dibenzoylmethane (10, 20, 30, 40, 50 μM; 2 hours) concentration-dependently increases the phosphorylated protein levels of Erk1/2, p38MAPK, JNK, AMPK, and Akt in HepG2 cells.
Dibenzoylmethane does not show significant cytotoxicity.
Dibenzoylmethane (200, 500 mg/kg/day; ip; for three consecutive days) pretreatment significantly reduces both the area and the severity of necrosis, as well as the leukocyte infiltration, at a dose of 200 mg/kg in wild-type and Nrf2 knockout mice.
Dibenzoylmethane protectes against CCl4-induced (1:49,v/v, 10 ml/kg) liver damage in wild-type mice.